Regenerative Medicine: Unlocking Patient Access and Commercial Potential

Regenerative medicine (RM) is a promising field that aims to replace or regenerate human cells, tissues, or organs to restore normal functions. It holds the potential to revolutionize treatment for previously untreatable diseases and chronic conditions. However, the high cost of RM may challenge the sustainability of healthcare insurers.

Format: Paperback / softback
Length: 232 pages
Publication date: 23 May 2023
Publisher: Taylor & Francis Ltd

Regenerative medicine (RM) is a rapidly evolving interdisciplinary field that seeks to replace or regenerate human cells, tissues, or organs to restore normal functions. This groundbreaking approach holds immense potential for revolutionising healthcare in the 21st century. RM offers new hope for individuals suffering from previously untreatable diseases, as well as holds promise for the treatment of common chronic conditions. The rapid advancements in biotechnology and a deeper understanding of disease pathophysiology have sparked a significant interest in the development of RM.

However, it is important to note that the high cost of RM poses a significant challenge to healthcare insurers, both public and private. This financial burden may hinder the widespread adoption and accessibility of RM treatments, potentially limiting the benefits that patients can reap from this innovative approach.

Despite these challenges, researchers and medical professionals are tirelessly working to overcome these obstacles and make RM a reality. With continued investment and dedication, it is possible that RM will become an integral part of healthcare, providing patients with new and innovative options for restoring their health and well-being.

Dimension: 229 x 152 (mm)
ISBN-13: 9781032431987